Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Plaquenil renal dosing Chloroquine method of action Keyword Research People who searched plaquenil for lupus rash also searched Plaquenil hydroxychloroquine is considered an older DMARD disease modifying anti-rheumatic drug. Plaquenil was actually first classified as an antimalarial drug, but it is also used to treat certain rheumatic and autoimmune conditions which are unrelated to malaria. Generally, Plaquenil is a treatment option as monotherapy used alone for mild rheumatoid arthritis or as combination. Hydroxychloroquine Plaquenil is used to treat malaria, lupus, and rheumatoid arthritis. Learn about side effects, warnings, dosage, and more. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Plaquenil-for-malaria-treatment-to-managing-lupus-ra Taking Plaquenil for Various Conditions and Treatment Tips, Taking Plaquenil for Rheumatoid Arthritis Plaquenil discount program Has anyone out there experienced ringing in the ears tinnitus as a side effect from taking Plaquenil? I was taking one pill a day for two months with no problems, but when rheumy increased dosage to 2 pills/day, within 4 days I developed ringing in my ears. It IS listed as a potential. Plaquenil and tinnitus DailyStrength. Hydroxychloroquine Side Effects, Dosage, Uses, and More. Hydroxychloroquine Reviews Everyday Health. Lupus is a chronic autoimmune disease in which the immune system attacks the body’s own healthy tissue and organs. It causes high levels of persistent inflammation, which can negatively affect nearly every part of the body the heart, joints, brain, kidneys, lungs and endocrine glands, for example. New research underscores the protective benefits of the medication hydroxychloroquine Plaquenil. The study compared clinical and laboratory information of more than 500 people with lupus and found that people who discontinued the treatment after less than one year were more likely to experience flares compared to those who took the drug for more than a year. In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine Plaquenil, for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes.